Therapeutic implications of fibroblast growth factor receptor inhibitors in a combination regimen for solid tumors (Review)
Hong Luo(Nanjing Agricultural University), Meiling Lan(Chongqing Medical University), Tao� Zhang(Ningbo University), Dong Li(Children's Hospital of Philadelphia), Ge Wang(Fudan University Shanghai Cancer Center), Oleksandr Ogorodniitchouk(Institute Cancer De La Loire Lucien Neuwirth), C. Lahmamssi(Institute Cancer De La Loire Lucien Neuwirth)
Cited by 17
Related Papers
Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis
|Signal Transduction and Targeted Therapy|2020|429
SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment
|Blood|2008|345
Mutations in PDGFRB Cause Autosomal-Dominant Infantile Myofibromatosis
|The American Journal of Human Genetics|2013|206
GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers
|The American Journal of Human Genetics|2016|183
Autism-Associated Mutations in ProSAP2/Shank3 Impair Synaptic Transmission and Neurexin–Neuroligin-Mediated Transsynaptic Signaling
|Journal of Neuroscience|2012|180